Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Tax loss season
View:
Post by subaru1 on Dec 21, 2023 2:42pm

Tax loss season

end dec. 27 2023.
Comment by okgonow on Dec 21, 2023 3:18pm
do you just regurgitate what is said on these forums  ...... TAX LOSS ...LOL its been at these levels for 2 years now no one is taking a tax loss selling LABS or if they are they are pretty desperate to sell at a 2 or 3 cent loss per share from the high of 24 months.. Please think about this: sometimes its better not to chime in
Comment by subaru1 on Dec 21, 2023 7:46pm
Well okgonow, i know people that kept losers for many years, more then 24 months and they finally decided to sell them for Tax loss, good for you if this has never happen to you....
Comment by alleyesonme on Dec 21, 2023 8:00pm
Good point....long time holders finally giving up....management is on track for positive ebita first half 2024..this share price is hard to swallow considering the state of the Corp...it may take the pharmaceutical partnership details to get this thing moving..I will continue holding..fundamentals always eventually translate to stock price...
Comment by mdjbrown on Dec 21, 2023 9:28pm
okgonow, for those who are fortunate to have spectacular capital gains in 2023, selling Labs shares at a huge loss and buying them back in 30 days could prove to be a brilliant tax reduction strategy. Many like myself have been holding here for a few years, and I could bank a 6 digit capital loss selling my shares at .065, if I had similiar gains elsewhere in 2023.  Gamble being, do you get ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities